Clinical Trial Update: Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

View source ↗

Summary

A clinical trial update examining factors that influence the selection and effectiveness of first-line biologic therapies for moderate-to-severe ulcerative coli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Ulcerative Colitis (UC) | Status: RECRUITING